Back

An Adeno-Associated Viral vector encoding Neurotrophin 3 injected into affected forelimb muscles modestly improves sensorimotor function after contusive mid-cervical spinal cord injury.

Sydney-Smith, J. D.; Megaro, V.; Spejo, A. B.; Moon, L. D. F.

2021-02-25 neuroscience
10.1101/2021.02.24.432676 bioRxiv
Show abstract

Traumatic spinal cord injury (SCI) in humans occurs most frequently in the cervical spine where it can cause substantial sensorimotor impairments to upper limb function. The altered input to spinal circuits below the lesion leads to maladaptive reorganisation which often leads to hyperreflexia in proprioceptive circuits. Neurotrophin 3 (NT3) is growth factor essential for the development of proprioceptive neurons. We have previously shown that following bilateral corticospinal tract axotomy, intramuscular delivery of an Adeno-Associated Viral vector encoding NT3 (AAV-NT3) induces proprioceptive circuit reorganisation linked to functional recovery. To assess its therapeutic effects following a clinically relevant bilateral C5-C6 contusion in rats, AAV-NT3 was injected intramuscularly into the dominant limb 24 hours after injury and forelimb function was assessed over 13 weeks. The injury generated hyperreflexia of a distal forelimb proprioceptive circuit. There was also loss of fine motor skills during reach-and-grasp and walking on a horizontal ladder. Ex vivo magnetic resonance imaging (MRI) revealed atrophy of the spinal cord and white matter disruption throughout the lesion site together with extensive loss of grey matter. Unexpectedly, animals treated with AAV-NT3 had a slightly smaller lesion in the regions close to the epicentre compared to PBS treated animals. Rats treated with AAV-NT3 showed subtly better performance on the horizontal ladder and transient benefits on reach-and-grasp. AAV-NT3 did not normalise hyperreflexia in a treated muscle. The treatment increased the amount of NT3 in treated muscles but, unexpectedly, serum levels were only elevated in a small subset of animals. These results show that this dose and delivery of AAV-NT3 may generate subtle improvements in locomotion but additional treatments will be required to overcome the widespread sensorimotor deficits caused by contusion injury.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Experimental Neurology
57 papers in training set
Top 0.1%
14.4%
2
Journal of Neurotrauma
27 papers in training set
Top 0.1%
14.4%
3
Neurorehabilitation and Neural Repair
17 papers in training set
Top 0.1%
10.1%
4
Scientific Reports
3102 papers in training set
Top 24%
4.9%
5
PLOS ONE
4510 papers in training set
Top 36%
4.0%
6
eneuro
389 papers in training set
Top 3%
3.3%
50% of probability mass above
7
Muscle & Nerve
10 papers in training set
Top 0.1%
3.1%
8
Frontiers in Neurology
91 papers in training set
Top 2%
2.6%
9
Journal of Neurology
26 papers in training set
Top 0.4%
2.1%
10
Brain Communications
147 papers in training set
Top 1%
2.1%
11
The Cerebellum
15 papers in training set
Top 0.1%
1.8%
12
The FASEB Journal
175 papers in training set
Top 1%
1.7%
13
Frontiers in Neuroscience
223 papers in training set
Top 4%
1.7%
14
Neuroscience
88 papers in training set
Top 1%
1.5%
15
Journal of Comparative Neurology
66 papers in training set
Top 0.5%
1.3%
16
Journal of Neuroscience Methods
106 papers in training set
Top 1%
1.3%
17
Frontiers in Cellular Neuroscience
79 papers in training set
Top 0.7%
1.2%
18
Brain
154 papers in training set
Top 4%
0.9%
19
Brain Stimulation
112 papers in training set
Top 1%
0.9%
20
Molecular Therapy
71 papers in training set
Top 2%
0.9%
21
Pain
70 papers in training set
Top 0.7%
0.9%
22
Neurotherapeutics
11 papers in training set
Top 0.5%
0.8%
23
Nature Communications
4913 papers in training set
Top 61%
0.8%
24
British Journal of Anaesthesia
14 papers in training set
Top 0.8%
0.7%
25
Molecular and Cellular Neuroscience
18 papers in training set
Top 0.7%
0.7%
26
eLife
5422 papers in training set
Top 61%
0.6%
27
iScience
1063 papers in training set
Top 37%
0.6%